Clinical Trial Update: S-Adenosyl-L-Methionine (SAMe) for Smoking Abstinence [Phase 2, Phase 3]

View source ↗

Summary

Results from Phase 2 and Phase 3 trials of S-Adenosyl-L-Methionine (SAMe) for smoking abstinence have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Dependence
• Tobacco Use Disorder

Drugs mentioned

• S-Adenosyl-L-Methionine (SAMe) (S-adenosyl-L-methionine)

Snippet

Sponsor: Mayo Clinic | Conditions: Tobacco Dependence | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2011-09-09